MCM
MRK icon

Mason Capital Management’s Merck MRK Stock Holding History

Mason Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-503,040
Closed -$24M – 32
2013
Q4 		$24M Buy
+503,040
New +$23M 0.44% 26

Other funds holding MRK

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mason Capital Management's MRK Position: Q1 2014 in Review

Mason Capital Management sold out of Merck (MRK) in Q1 2014, closing a stake of 503,040 shares — an estimated $24M sold.

Mason Capital Management first reported a position in MRK in Q4 2013 and held it in 1 quarter. The position peaked at $24M in Q4 2013. 1,602 funds tracked by Wall St. Rank hold MRK as of Q1 2014.

  • Mason Capital Management reported no remaining Merck position as of Q1 2014 after selling out during the quarter.
  • Mason Capital Management sold 503,040 Merck shares in Q1 2014, an estimated $24M.
  • Mason Capital Management first reported a position in Merck in Q4 2013 and held it in 1 quarter.
  • Mason Capital Management's Merck position peaked at $24M in Q4 2013.
  • 1,602 funds tracked by Wall St. Rank held Merck as of Q1 2014.

Based on Mason Capital Management's 13F filing for Q1 2014, filed 15 May 2014.